Figure 2D shows that when patients with the mesenchymal subtype of glioblastoma were stratified according to PLAUR mRNA expression and those in the top 25% were compared with those in the bottom 25%, high levels of PLAUR mRNA significantly predicted worsened patient survival, as determined by Log-rank test (p = 0.004). This evidence concerns the gene PLAUR and glioblastoma.